Synergistic Effect of Ferroptosis-Inducing Nanoparticles and X-Ray Irradiation Combination Therapy

被引:10
|
作者
Bae, Chaewon [1 ]
Hernandez Millares, Rodrigo [2 ]
Ryu, Suhyun [3 ]
Moon, Hyowon [5 ]
Kim, Dongwoo [3 ]
Lee, Gyubok [3 ]
Jiang, Zhuomin [3 ]
Park, Min Hee [4 ]
Kim, Kyung Hwan [5 ]
Koom, Woong Sub [5 ]
Ye, Sung-Joon [3 ,6 ,7 ,8 ]
Lee, Kangwon [3 ,8 ]
机构
[1] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Program Nanosci & Technol, Seoul 08826, South Korea
[2] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Program Biomed Radiat Sci, Seoul 08826, South Korea
[3] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Appl Bioengn, Seoul 08826, South Korea
[4] THEDONEE, 156 Gwanggyo Ro, Suwon 16506, Gyeonggi Do, South Korea
[5] Yonsei Univ, Coll Med, Heavy Ion Therapy Res Inst, Dept Radiat Oncol,Yonsei Canc Ctr, Seoul 03722, South Korea
[6] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul 03080, South Korea
[7] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 16229, South Korea
[8] Seoul Natl Univ, Res Inst Convergence Sci, Seoul 08826, South Korea
基金
新加坡国家研究基金会;
关键词
combination therapy; ferroptosis; monte carlo simulation; radiotherapy; tumor treatment; X-ray irradiation; MONTE-CARLO; CLONOGENIC-ASSAY; CANCER; TUMOR; CELLS; IRON; RADIOTHERAPY; APOPTOSIS; PROGRESS; MODELS;
D O I
10.1002/smll.202310873
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Ferroptosis, characterized by the induction of cell death via lipid peroxidation, has been actively studied over the last few years and has shown the potential to improve the efficacy of cancer nanomedicine in an iron-dependent manner. Radiation therapy, a common treatment method, has limitations as a stand-alone treatment due to radiation resistance and safety as it affects even normal tissues. Although ferroptosis-inducing drugs help alleviate radiation resistance, there are no safe ferroptosis-inducing drugs that can be considered for clinical application and are still in the research stage. Here, the effectiveness of combined treatment with radiotherapy with Fe and hyaluronic acid-based nanoparticles (FHA-NPs) to directly induce ferroptosis, considering the clinical applications is reported. Through the induction of ferroptosis by FHA-NPs and apoptosis by X-ray irradiation, the therapeutic efficiency of cancer is greatly improved both in vitro and in vivo. In addition, Monte Carlo simulations are performed to assess the physical interactions of the X-rays with the iron-oxide nanoparticle. The study provides a deeper understanding of the synergistic effect of ferroptosis and X-ray irradiation combination therapy. Furthermore, the study can serve as a valuable reference for elucidating the role and mechanisms of ferroptosis in radiation therapy. The therapeutic efficiency of cancer treatment is considerably improved through the induction of ferroptosis via FHA-NPs and apoptosis via X-ray irradiation. An enhanced cellular killing effect is observed both in vitro and in vivo. The results provide a better understanding of the synergistic effect of combination therapy consisting of ferroptosis and ionizing irradiation.image
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer
    Huang, Mengjun
    Teng, Qiliang
    Cao, Fei
    Huang, Jinsheng
    Pang, Jun
    BIOMATERIALS SCIENCE, 2024, 12 (07) : 1617 - 1629
  • [2] Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo
    Shibata, Yuki
    Yasui, Hironobu
    Higashikawa, Kei
    Miyamoto, Naoki
    Kuge, Yuji
    PLOS ONE, 2019, 14 (12):
  • [3] Ferroptosis-Inducing Nanomedicine for Cancer Therapy
    Wang, Yang
    Liu, Tianfu
    Li, Xiang
    Sheng, Hui
    Ma, Xiaowen
    Hao, Liang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [4] Synergistic Therapy of Melanoma by Co-Delivery of Dacarbazine and Ferroptosis-Inducing Ursolic Acid Using Biomimetic Nanoparticles
    Hou, Wenjun
    Zou, Yifan
    Li, Jie
    Jiang, Hui
    Li, Jinyu
    Wu, Jie
    Zhu, Senlin
    Ding, Yan
    Xu, Huae
    Jia, Feng
    Li, Xiaolin
    ACS OMEGA, 2024, 9 (40): : 41532 - 41543
  • [5] A Ferroptosis-Inducing Arsenene-Iridium Nanoplatform for Synergistic Immunotherapy in Pancreatic Cancer
    Zhao, Xinyang
    Wang, Xingyun
    Zhang, Wei
    Tian, Tian
    Zhang, Jingyi
    Wang, Jing
    Wei, Wei
    Guo, Zijian
    Zhao, Jing
    Wang, Xiuxiu
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (15)
  • [6] A bibliometric study and visualization analysis of ferroptosis-inducing cancer therapy
    Zhang, Jun
    Luo, Zai
    Zheng, Yang
    Cai, Qianqian
    Jiang, Jie
    Zhang, Haoliang
    Duan, Mingyu
    Chen, Yanmin
    Xia, Jiayang
    Qiu, Zhengjun
    Zeng, Jvdan
    Huang, Chen
    HELIYON, 2023, 9 (09)
  • [7] Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma
    Wang, Luyang
    Tong, Le
    Xiong, Zecheng
    Chen, Yi
    Zhang, Ping
    Gao, Yan
    Liu, Jing
    Yang, Lei
    Huang, Chunqi
    Ye, Gaoqi
    Du, Jing
    Liu, Huibiao
    Yang, Wei
    Wang, Ying
    JOURNAL OF NANOBIOTECHNOLOGY, 2024, 22 (01)
  • [8] A mini-review and perspective on ferroptosis-inducing strategies in cancer therapy
    Wang, Shuaifei
    Liao, Hongwei
    Li, Fangyuan
    Ling, Daishun
    CHINESE CHEMICAL LETTERS, 2019, 30 (04) : 847 - 852
  • [9] Arsenic-Loaded Biomimetic Iron Oxide Nanoparticles for Enhanced Ferroptosis-Inducing Therapy of Hepatocellular Carcinoma
    Liu, Junfeng
    Li, Xi
    Chen, Jiayao
    Zhang, Xiaoting
    Guo, Jingpei
    Gu, Jinyan
    Mei, Chaoming
    Xiao, Yitai
    Peng, Chao
    Liu, Junbin
    Hu, Xiaojun
    Zhang, Ke
    Li, Dan
    Zhou, Bin
    ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (05) : 6260 - 6273
  • [10] Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy
    Xiang, Debiao
    Zhou, Lili
    Yang, Rui
    Yuan, Fang
    Xu, Yilin
    Yang, Yuan
    Qiao, Yong
    Li, Xin
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 2091 - 2112